Generic name |
valganciclovir |
---|---|
Strength |
450 mg, 50 mg / mL |
Form | oral tablet, oral solution |
Special Authority criteria |
Approval period |
---|---|
For the prophylaxis of cytomegalovirus (CMV) infection post stem cell transplant, in patients who test positive for CMV upon polymerase chain reaction (PCR) laboratory testing. Notes:
Valganciclovir should be dose-adjusted according to renal function. |
Approval lasts until there are 2 consecutive negative CMV PCR results obtained 1 week apart. |